Rodrigo Cé[Author] - Search Results

Year	Number of Results
2020	2
2021	5
2024	0

1

EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma.

de Cristo Soares Alves A, Lavayen V, de Fraga Dias A, Bruinsmann FA, Scholl JN, Cé R, Visioli F, Oliveira Battastini AM, Stanisçuaski Guterres S, Figueiró F, Raffin Pohlmann A. de Cristo Soares Alves A, et al. Among authors: ce r. Nanomedicine (Lond). 2021 Aug;16(20):1775-1790. doi: 10.2217/nnm-2021-0169. Epub 2021 Jul 27. Nanomedicine (Lond). 2021. PMID: 34313137

2

Nanoformulation Shows Cytotoxicity against Glioblastoma Cell Lines and Antiangiogenic Activity in Chicken Chorioallantoic Membrane.

Dallemole DR, Terroso T, Alves ACS, Scholl JN, Onzi GR, Cé R, Paese K, Battastini AMO, Guterres SS, Figueiró F, Pohlmann AR. Dallemole DR, et al. Among authors: ce r. Pharmaceutics. 2021 Jun 11;13(6):862. doi: 10.3390/pharmaceutics13060862. Pharmaceutics. 2021. PMID: 34208088 Free PMC article.

3

Galleria mellonella Larvae as an In Vivo Model to Evaluate the Toxicity of Polymeric Nanocapsules.

Cé R, Silva RC, Trentin DS, Marchi JGB, Paese K, Guterres SS, Macedo AJ, Pohlmann AR. Cé R, et al. J Nanosci Nanotechnol. 2020 Mar 1;20(3):1486-1494. doi: 10.1166/jnn.2020.17170. J Nanosci Nanotechnol. 2020. PMID: 31492311

4

Folic acid-doxorubicin polymeric nanocapsules: A promising formulation for the treatment of triple-negative breast cancer.

Cé R, Couto GK, Pacheco BZ, Dallemole DR, Paschoal JD, Pacheco BS, Guterres SS, Seixas F, Collares T, Pohlmann AR. Cé R, et al. Eur J Pharm Sci. 2021 Oct 1;165:105943. doi: 10.1016/j.ejps.2021.105943. Epub 2021 Jul 11. Eur J Pharm Sci. 2021. PMID: 34260893

5

Folic Acid-Doxorubicin-Double-Functionalized-Lipid-Core Nanocapsules: Synthesis, Chemical Structure Elucidation, and Cytotoxicity Evaluation on Ovarian (OVCAR-3) and Bladder (T24) Cancer Cell Lines.

Cé R, Lavayen V, Couto GK, De Marchi JGB, Pacheco BZ, Natividade LA, Fracari TO, Ciocheta TM, de Cristo Soares Alves A, Jornada DS, Guterres SS, Seixas F, Collares T, Pohlmann AR. Cé R, et al. Pharm Res. 2021 Feb;38(2):301-317. doi: 10.1007/s11095-021-02989-y. Epub 2021 Feb 19. Pharm Res. 2021. PMID: 33608808

6

A set of synthetic data, antibacterial evaluation and bacterial interaction with lipid-core nanocapsules containing fusidic acid.

Cé R, Pacheco BZ, Ciocheta TM, Barbosa FS, Alves AC, Dallemole DR, Lavayen V, Guterres SS, Steppe M, Pohlmann AR. Cé R, et al. Data Brief. 2021 Apr 24;36:107089. doi: 10.1016/j.dib.2021.107089. eCollection 2021 Jun. Data Brief. 2021. PMID: 34026983 Free PMC article.

7

Chitosan-Coated Lipid-Core Nanocapsules Functionalized with Gold-III and Bevacizumab Induced In Vitro Cytotoxicity against C6 Cell Line and In Vivo Potent Antiangiogenic Activity.

de Cristo Soares Alves A, Lavayen V, Figueiró F, Dallemole DR, de Fraga Dias A, Cé R, Battastini AMO, Guterres SS, Pohlmann AR. de Cristo Soares Alves A, et al. Among authors: ce r. Pharm Res. 2020 May 8;37(6):91. doi: 10.1007/s11095-020-02804-0. Pharm Res. 2020. PMID: 32385723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year